IMPAX LABORATORIES INC's ticker is IPXL and the CUSIP is 45256B101. A total of 198 filers reported holding IMPAX LABORATORIES INC in Q4 2015. The put-call ratio across all filers is 0.81 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $226,000 | -41.9% | 6,430 | -24.0% | 0.06% | -17.8% |
| Q2 2015 | $389,000 | -21.3% | 8,466 | -19.7% | 0.07% | -16.1% |
| Q1 2015 | $494,000 | +30.7% | 10,547 | -11.7% | 0.09% | +42.6% |
| Q4 2014 | $378,000 | +33.6% | 11,941 | 0.0% | 0.06% | +69.4% |
| Q3 2014 | $283,000 | -13.7% | 11,941 | +9.2% | 0.04% | +2.9% |
| Q2 2014 | $328,000 | +13.5% | 10,931 | 0.0% | 0.04% | +6.1% |
| Q1 2014 | $289,000 | +5.1% | 10,931 | 0.0% | 0.03% | -5.7% |
| Q4 2013 | $275,000 | +22.8% | 10,931 | 0.0% | 0.04% | -2.8% |
| Q3 2013 | $224,000 | +2.8% | 10,931 | 0.0% | 0.04% | -16.3% |
| Q2 2013 | $218,000 | – | 10,931 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aravt Global | 2,670,000 | $125,143,000 | 9.40% |
| Krensavage Asset Management, LLC | 410,944 | $19,261,000 | 8.77% |
| BANBURY PARTNERS LLC | 292,660 | $13,717,000 | 8.70% |
| Slate Path Capital LP | 1,935,000 | $90,693,000 | 5.72% |
| BLUE JAY CAPITAL MANAGEMENT, LLC | 285,000 | $13,358,000 | 4.69% |
| Orbimed Advisors | 6,678,000 | $312,998,000 | 2.67% |
| Pennant Capital Management, LLC | 2,025,000 | $94,912,000 | 1.78% |
| Iguana Healthcare Management, LLC | 75,000 | $3,515,000 | 1.48% |
| Leonard Capital Management, Inc. | 89,235 | $4,182,000 | 1.44% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 250,000 | $11,718,000 | 1.23% |